Nilotinib [clinicaltrials_resource:688b96e7efc212b61e13ca0e9d0e2806]
A Phase l/ll Study of AMN107 in Adult Patients With Glivec-intolerant CML or Relapsed-refractory Ph+ALL [clinicaltrials:NCT00384228]Pharmacokinetics of Nilotinib in Subjects With Impaired Hepatic Function and Healthy Subjects With Normal Hepatic Function [clinicaltrials:NCT00418626]Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase [clinicaltrials:NCT01061177]Safety and Efficacy of Nilotinib in Newly Diagnosed Chronic Myeloid Leukemia Patients [clinicaltrials:NCT01254188]Study to Evaluate Nilotinib in Adult Patients With Imatinib-resistant or Imatinib-intolerant Chronic Myelogenous Leukemia (CML), or Relapse/Refractory Ph+ Acute Lymphoblastic Leukemia (ALL) (Extension Study) [clinicaltrials:NCT01279473]Efficacy of Nilotinib in Adult Patients With Gastrointestinal Stromal Tumors Resistant to Imatinib and Sunitinib [clinicaltrials:NCT01289028]
intervention [clinicaltrials_vocabulary:intervention]
Nilotinib [clinicaltrials_resource:688b96e7efc212b61e13ca0e9d0e2806]
Bio2RDF identifier
688b96e7efc212b61e13ca0e9d0e2806
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:688b96e7efc212b61e13ca0e9d0e2806
arm group [clinicaltrials_vocabulary:arm-group]
intervention name [clinicaltrials_vocabulary:intervention-name]
other name [clinicaltrials_vocabulary:other-name]
identifier
clinicaltrials_resource:688b96e7efc212b61e13ca0e9d0e2806
title
Nilotinib
@en
type
label
Nilotinib [clinicaltrials_resource:688b96e7efc212b61e13ca0e9d0e2806]
@en